Ciqiu Yang

1.0k total citations · 1 hit paper
58 papers, 663 citations indexed

About

Ciqiu Yang is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ciqiu Yang has authored 58 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 31 papers in Cancer Research and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ciqiu Yang's work include Breast Cancer Treatment Studies (26 papers), Cancer Treatment and Pharmacology (12 papers) and Breast Lesions and Carcinomas (10 papers). Ciqiu Yang is often cited by papers focused on Breast Cancer Treatment Studies (26 papers), Cancer Treatment and Pharmacology (12 papers) and Breast Lesions and Carcinomas (10 papers). Ciqiu Yang collaborates with scholars based in China, Hong Kong and Taiwan. Ciqiu Yang's co-authors include Kun Wang, Liulu Zhang, Teng Zhu, Mei Yang, Fei Ji, Minyi Cheng, Hongfei Gao, Jieqing Li, Yi‐Jie Huang and Ying Lin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ciqiu Yang

52 papers receiving 657 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study

2023 94 citations Yühong Huang, Teng Zhu et al. EClinicalMedicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ciqiu Yang China	14	298	238	222	141	121	58	663
Liulu Zhang China	13	250 0.8×	195 0.8×	159 0.7×	128 0.9×	87 0.7×	51	545
Heung Kyu Park South Korea	12	337 1.1×	331 1.4×	116 0.5×	135 1.0×	103 0.9×	38	600
Ines Gruber Germany	18	349 1.2×	265 1.1×	205 0.9×	299 2.1×	97 0.8×	39	764
N. Fersis Germany	14	266 0.9×	275 1.2×	200 0.9×	108 0.8×	96 0.8×	37	684
P. Chérel France	15	345 1.2×	329 1.4×	243 1.1×	285 2.0×	164 1.4×	39	816
Minyi Cheng China	11	186 0.6×	166 0.7×	141 0.6×	79 0.6×	92 0.8×	37	422
Martín Velasco Spain	14	423 1.4×	209 0.9×	389 1.8×	316 2.2×	111 0.9×	24	816
Soong June Bae South Korea	15	273 0.9×	347 1.5×	112 0.5×	89 0.6×	88 0.7×	84	645
Nirmala Pathmanathan Australia	14	273 0.9×	245 1.0×	95 0.4×	152 1.1×	63 0.5×	40	553
Massimo Rinaldo Italy	15	299 1.0×	307 1.3×	160 0.7×	147 1.0×	104 0.9×	29	690

Countries citing papers authored by Ciqiu Yang

Since Specialization

Citations

This map shows the geographic impact of Ciqiu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ciqiu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ciqiu Yang more than expected).

Fields of papers citing papers by Ciqiu Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ciqiu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ciqiu Yang. The network helps show where Ciqiu Yang may publish in the future.

Co-authorship network of co-authors of Ciqiu Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Ciqiu Yang. A scholar is included among the top collaborators of Ciqiu Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ciqiu Yang. Ciqiu Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Ciqiu, Yitian Chen, Junsheng Zhang, et al.. (2025). Differences in HER2-0 and HER2-low Breast Cancer: Androgen Receptor and Programmed Death Ligand 1 as Predictive Factors. Journal of Breast Cancer. 28(1). 23–23.

Sun, Zicheng, Hua‐Zhen Xu, Guanming Lu, et al.. (2025). AKT1 Phosphorylates FDX1 to Promote Cuproptosis Resistance in Triple‐Negative Breast Cancer. Advanced Science. 12(17). e2408106–e2408106. 14 indexed citations

Yang, Jing, Luojia Wu, Fan Lü, et al.. (2025). Association between arsenic exposure and intrauterine growth restriction: A systematic review and meta-analysis. PLoS ONE. 20(6). e0320603–e0320603.

Lu, Bing, Li Wang, Mingsen Li, et al.. (2024). Phase separation of phospho-HDAC6 drives aberrant chromatin architecture in triple-negative breast cancer. Nature Cancer. 5(11). 1622–1640. 20 indexed citations

Yang, Ciqiu, Peiyong Li, Yitian Chen, et al.. (2024). Pooled analysis of NeoCARH and NeoCART trials: patient-reported outcomes in patients with early-stage breast cancer receiving platinum-based or anthracycline-based neoadjuvant chemotherapy. Supportive Care in Cancer. 32(6). 401–401.

Li, Xi, Ciqiu Yang, Mei Yang, et al.. (2024). CircXPO6 promotes breast cancer progression through competitively inhibiting the ubiquitination degradation of c-Myc. Molecular and Cellular Biochemistry. 480(3). 1731–1745. 5 indexed citations

Yan, Cheng, Liqun Zhou, Guozhi Zhang, et al.. (2023). Improved small vessel visibility in diabetic foot arteriography using dual-energy CT. Clinical Radiology. 79(3). e424–e431. 1 indexed citations

Yang, Meiling, Ciqiu Yang, Dong Ma, et al.. (2023). Single-cell analysis reveals cellular reprogramming in advanced colon cancer following FOLFOX-bevacizumab treatment. Frontiers in Oncology. 13. 1219642–1219642. 3 indexed citations

Xiao, Lei, C.Z. Zhou, Wenquan Niu, et al.. (2023). 98P Short-course radiotherapy based total neoadjuvant therapy combined with tislelizumab in the treatment of locally advanced rectal cancer: Mid-term report of a phase II, open-label, randomized controlled trial. Immuno-Oncology Technology. 20. 100570–100570. 1 indexed citations

10.

Huang, Yühong, Teng Zhu, Xiaoling Zhang, et al.. (2023). Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study. EClinicalMedicine. 58. 101899–101899. 94 indexed citations breakdown →

11.

Zhu, Teng, Xiaocheng Lin, Tingfeng Zhang, et al.. (2022). A Model Incorporating Axillary Tail Position on Mammography for Preoperative Prediction of Non-sentinel Lymph Node Metastasis in Patients with Initial cN+ Breast Cancer after Neoadjuvant Chemotherapy. Academic Radiology. 29(12). e271–e278. 2 indexed citations

12.

Zhang, Liulu, Minyi Cheng, Yuanqi Chen, et al.. (2021). Visualization positioning-guided biopsy of suspicious breast microcalcifications: a retrospective cohort study. Annals of Translational Medicine. 9(21). 1620–1620. 2 indexed citations

13.

Zhang, Junsheng, Ciqiu Yang, Yi Zhang, et al.. (2021). Effects of Surgery on Prognosis of Young Women With Operable Breast Cancer in Different Marital Statuses: A Population-Based Cohort Study. Frontiers in Oncology. 11. 666316–666316. 6 indexed citations

14.

Gao, Hongfei, Weiping Li, Teng Zhu, et al.. (2020). Adjuvant chemotherapy could benefit early-stage ER/PR positive mucinous breast cancer: A SEER-based analysis. The Breast. 54. 79–87. 5 indexed citations

15.

Yang, Ciqiu, Yi Zhang, Junsheng Zhang, et al.. (2020). Comparison of Overall Survival Between Invasive Lobular Breast Carcinoma and Invasive Ductal Breast Carcinoma: A Propensity Score Matching Study Based on SEER Database. Frontiers in Oncology. 10. 590643–590643. 37 indexed citations

16.

Gao, Xinya, Yuanhui Lai, Zhanqiang Zhang, et al.. (2020). Long Non-coding RNA RP11-480I12.5 Promotes the Proliferation, Migration, and Invasion of Breast Cancer Cells Through the miR-490-3p-AURKA-Wnt/β-Catenin Axis. Frontiers in Oncology. 10. 948–948. 9 indexed citations

17.

Zhu, Teng, Mei Yang, Fei Ji, et al.. (2020). Comparison of the efficacy and safety of the EC-T (epirubicin/cyclophosphamide followed by docetaxel) and TCb (docetaxel/carboplatin) neoadjuvant regimens in early TOP2A-normal stage II-III breast cancer.. Neoplasma. 67(6). 1409–1415. 6 indexed citations

18.

Ji, Bohai, et al.. (2019). A pooled meta-analysis of PD-1/L1 inhibitors incorporation therapy for advanced non-small cell lung cancer. SHILAP Revista de lepidopterología. 1 indexed citations

19.

Gao, Hongfei, Ciqiu Yang, Minyi Cheng, et al.. (2018). Prognostic Significance of Mesenchymal–Epithelial Transition in Triple-Negative Breast Cancers. Clinical Breast Cancer. 18(5). e961–e966. 5 indexed citations

20.

Yu, Xu, Jianying Zhou, Song Fan, et al.. (2016). Association between BHMT gene rs3733890 polymorphism and cancer risk: evidence from a meta-analysis. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact